Archives d’Auteur: h21joubin

Maxime Moulard is CSO for BioCytex, a company that develops quantitative flow cytometry application kits. BioCytex is performing R&D and clinical investigations for major worldwide pharmaceutical companies. Biocytex is currently involved in developing diagnostic tools that can be used in a large spectrum of diseases including cancer, inflammatory diseases and hemostasis. Maxime has been involved in establishing and managing major corporate collaborations and partnerships (Eli Lilly, Sanofi-Aventis) as well as numerous academic and Institutional collaborations.
Prior to joining BioCytex in 2001, he was Visiting Scientist at The Scripps Research Institute (TSRI), in La Jolla, from 1998 to 2000. His scientific interests led him to develop new methods to generate and characterize human monoclonal antibodies using phage-display technologies. He received his Ph.D. in Biochemistry from the University Pierre & Marie Curie (Paris, France) and completed his post-doctoral training at the Institute für Virology in Marburg, Germany. He has published over 30 original manuscripts, book chapters, patents and reviews and has been a regular contributor of original research to the field of protein interaction and signaling mechanisms.

Valérie Philippon, Director of Publication Strategy and Management at Vertex

Valérie Philippon is the Director of Publication Strategy and Management at Vertex Pharmaceuticals, a company based in Cambridge, MA that is seeking to transform the way serous diseases are treated. She is responsible for the development and execution of Publication Strategy for Vertex HCV franchise. Valérie has over 15 years of experience in Research, Development, Program & Portfolio Management, Medical Writing and Publication Planning. She received her Ph.D. in Microbiology from the University of Paris, France where she studied the molecular pathogenesis of retroviruses. She continued in research doing a post-doctoral fellowship at Harvard School of Public Health under the direction of Dr Max Essex and studying the role of Vpr and Vpx proteins in HIV and SIV pathogenesis. Following the completion of her fellowship she accepted a scientist position at Therion Biologics where, as a scientist and program manager, she participated in the discovery and development of cancer immunotherapies and was responsible for the company HIV vaccine development. She then joined Idenix Pharmaceuticals as a Medical Writer where her responsibilities extended from helping clinicians and scientists to write abstracts, conference presentations and manuscripts to coordinate publication planning for the company’s HBV, HCV and HIV drug candidates.

Le Président Aoun nous présentera le modèle Northeastern, le renforcement de ses collaborations internationales ainsi que les liens très forts tissés entre l’université et le monde de l’entreprise. Northeastern University a été élue en 2008, meilleure université américaine pour le placement professionnel de ses étudiants par la Princeton Review.

Joseph E. Aoun, an internationally known scholar in linguistics, is the seventh president of Northeastern University-a preeminent global, experiential, research university. Since his presidency began in August 2006, he has charted an ambitious and distinctive course to advance Northeastern. At the heart of his vision is a commitment to strengthen the University’s leadership position in experiential and cooperative education; create global programs with an urban perspective; foster a research environment where faculty uncover solutions to real-world problems; and build innovative partnerships so that Northeastern can better serve its students, its city, the nation, and the world.

President Aoun serves on the boards of directors of the American Council on Education, Artists for Humanity, the Boston Private Industry Council, Boston World Partnerships, Jobs for Mass, and the New England Council.

He is a member of the Executive Committee of the Greater Boston Chamber of Commerce, a member of the Massachusetts Business Roundtable and Massachusetts Math & Science Initiative, and serves on the Leadership Council for the Massachusetts Life Sciences Collaborative and as cochair of the City to City Boston initiative.

President Aoun received his PhD in linguistics and philosophy from the Massachusetts Institute of Technology in 1981; his Diploma of Advanced Studies in General and Theoretical Linguistics from the University of Paris (France) VIII in 1977; and his Masters in Oriental Languages and Literature from Saint Joseph University (Beirut, Lebanon) in 1975. In 2006 he was presented with the Chevalier de L’ordre des Palmes Academiques from the French Government, and in May of 2007 Hebrew Union College – Jewish Institute of Religion presented him the degree of Doctor of Humane Letters, honoris causa. President Aoun has published seven books and written more than 40 articles.